CVRx, Inc. Common Stock (CVRX) stock fundamentals

Company overview

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Daily valuation snapshot

These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing CVRX with another company.

No matching rows. Clear the filter to see all records.

Read CVRX's valuation metrics

1. Company size

   CVRx, Inc. Common Stock's recorded market capitalization is $44,757,882.96. It measures the market value of the company's equity, rather than its revenue or cash balance.

2. Price relative to earnings

   P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.

3. Price relative to book equity

   CVRX's recorded price-to-book ratio is 2.24. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.

Research CVRx, Inc. Common Stock with Aurora

Use the snapshot above to ask a specific question about CVRX. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.

Continue the research

Follow CVRX's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.